HISTIOCYTIC SARCOMA
Clinical trials for HISTIOCYTIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC SARCOMA trials appear
Sign up with your email to follow new studies for HISTIOCYTIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare immune disorders: targeted pill shows promise
Disease control Recruiting nowThis study tests a drug called cobimetinib in children and adults with Langerhans cell histiocytosis (LCH) and related disorders that have not responded to standard treatment. Cobimetinib blocks a faulty growth signal in the cells causing the disease. The goal is to shrink tumors…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug Q702 aims to boost immune system against Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug, Q702, in about 46 adults with certain blood cancers or related diseases that have not responded to standard treatments. Q702 works by helping the immune system attack cancer cells and supporting normal blood cell production. The main goals…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 19, 2026 11:47 UTC